Home » Topics » BioWorld Science

BioWorld Science
RSS

Estrogenic compounds from Sankyo

Aug. 30, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Prophylactic tibolone shown effective in 2 year study

Aug. 30, 1996

Study finds latanoprost more effective than timolol

Aug. 30, 1996

BRCA1 licensing agreement

Aug. 30, 1996

Minoxidil effective and safe for chemotherapy-induced hair loss in women

Aug. 30, 1996

Gene involved in colon cancer development revealed

Aug. 30, 1996

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Cancer genetics joint venture

Aug. 30, 1996

Inflazyme/SuperGen future licensing agreement

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...